BUGWORKS Research

Bugworks is a drug research and development company aimed at developing new drugs to combat antimicrobial resistance (AMR). Bugworks has proposed a new bacterial topoisomerase inhibitor (NBTI), which can effectively fight against a variety of drug-resistant bacterial pathogens.